Cite
HARVARD Citation
Igarashi, K. et al. (2018). Temozolomide regresses a doxorubicin‐resistant undifferentiated spindle‐cell sarcoma patient‐derived orthotopic xenograft (PDOX): precision‐oncology nude‐mouse model matching the patient with effective therapy. Journal of cellular biochemistry. 119 (8), pp. 6598-6603. [Online].